| Wed, Dec 9, 2009 | | • | Pharming Confirms Interaction With US FDA for Rhucin
Marketwire (Wed, Dec 9)
| | Mon, Oct 26, 2009 | | • | Pharming to present at Bio-Europe 2009
Marketwire (Mon, Oct 26)
| | Thu, Oct 22, 2009 | | • | Pharming recombinant human C1 inhibitor: Results in pre-clinical ischaemic reperfusion model confirm potential for new indications
Marketwire (Thu, Oct 22)
| | Fri, Oct 16, 2009 | | • | Q3 2009 PHARMING GROUP NV LEIDEN Earnings Release - Time Not Supplied
CCBN (Fri, Oct 16)
| | • | Pharming announces Third Quarter 2009 Results
Marketwire (Fri, Oct 16)
| | Tue, Oct 13, 2009 | | • | Pharming confirms successful closing of offer on convertible bonds
Marketwire (Tue, Oct 13)
| | Thu, Oct 8, 2009 | | • | Pharming finalizes conversion of 70% of outstanding bonds
Marketwire (Thu, Oct 8)
| | Mon, Oct 5, 2009 | | • | Pharming secures additional EUR 10 million financing from Yorkville Advisors
Marketwire (Mon, Oct 5)
| | Wed, Sep 30, 2009 | | • | Pharming provides update on outstanding shares
Marketwire (Wed, Sep 30)
| | • | Pharming receives commitment for conversion of 70% of outstanding bonds
Marketwire (Wed, Sep 30)
| | Wed, Sep 23, 2009 | | • | Pharming's Marketing Authorisation Application for Rhucin Validated by the European Medicines Agency (EMEA)
Marketwire (Wed, Sep 23)
| | Mon, Sep 21, 2009 | | • | Pharming announces offer to holders of convertible bonds with financial support of current shareholders
Marketwire (Mon, Sep 21)
| | Thu, Sep 17, 2009 | | • | Pharming to present at UBS Global Life Sciences Conference
Marketwire (Thu, Sep 17)
| | Wed, Sep 16, 2009 | | • | DNage initiates observational study in children suffering from Cockayne Syndrome
Marketwire (Wed, Sep 16)
| | Fri, Sep 11, 2009 | | • | Pharming provides update on outstanding number of shares
Marketwire (Fri, Sep 11)
| | Thu, Sep 3, 2009 | | • | Pharming submits marketing authorisation application for Rhucin(R) to the EMEA
Marketwire (Thu, Sep 3)
| | Fri, Aug 28, 2009 | | • | Pharming gives update on outstanding number of shares
Marketwire (Fri, Aug 28)
| | Fri, Aug 14, 2009 | | • | Pharming Group N.V.: FDA approves Investigational New Drug application for Prodarsan(R) in Cockayne Syndrome patients
Marketwire (Fri, Aug 14)
| | Fri, Jul 17, 2009 | | • | Pharming announces Financial Results First Half Year 2009
Marketwire (Fri, Jul 17)
| | Tue, Jul 14, 2009 | | • | Pharming provides update on outstanding number of shares
Marketwire (Tue, Jul 14)
|
Add PHGUF.PK News to My Yahoo!:
 
| |
|
0.49% Nasdaq 
Headlines
